New European survey highlights ischaemic stroke protection as treatment priority for patients with atrial fibrillation
Findings from a pan-European online survey...
28 May 2013 | By Boehringer Ingelheim
Findings from a pan-European online survey...
List view / Grid view
Findings from a pan-European online survey...
28 May 2013 | By Boehringer Ingelheim
Findings from a pan-European online survey...
1 Mission 1 Million announces its plans to support ongoing…
23 May 2012 | By Boehringer Ingelheim
1 Mission 1 Million announces its plans to support ongoing work in atrial fibrillation...
1 Mission 1 Million launches petition and unique fundraising platform...
22 May 2012 | By Boehringer Ingelheim
1 Mission 1 Million launches petition and unique fundraising platform...
1 Mission 1 Million announces plans to launch an exciting…
18 April 2012 | By Boehringer Ingelheim
1 Mission 1 Million announces plans to launch an exciting new phase of the initiative...
Pradaxa®1 (dabigatran etexilate) approved...
4 August 2011 | By Ogilvy Healthworld UK Limited
Pradaxa®1 (dabigatran etexilate) approved...